drugset / Trial / NCT00434681
Paracetamol Oral Paediatric Suspension at 4.8% : Study of Acceptability and Safety.
Non-randomizedSingle-groupOpen-label
Summary
Evaluate the acceptability over 24 hours of a new paracetamol formulation 4.8% paediatric oral suspension in children weighing between 3 and 26 kg including limits
Timeline
- Start
- 2006-10
- Primary completion
- —
- Completion
- 2007-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Acetaminophen | Small molecule | 4.8 % | Oral |
Indications
No indication recorded.